HIGH END CELLOMICS MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2023 - 2030)

High End Cellomics Market, By Product Type (Instruments, Reagents and Consumables, and Software & Services), By Application (Drug discovery, Cancer Research, Neuroscience, Stem Cell Research and Regenerative Medicine, Personalized Medicine, and Others), By Technology (Microscopy, Flow Cytometry, Single-cell Genomics, Mass Spectrometry, Next Generation Sequencing, and Others), By End User (Biotechnology & Pharmaceutical Companies, Hospitals & Diagnostic Laboratories, Contract Research Organizations, and Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

Recent Developments:

New product launches:

In January 2023, Axion BioSystems, a life science company, announced the launch of the Omni Pro 12 to its Omni live-cell imaging product range. The new platform gives scientists and drug developers doing live-cell imaging tests more flexibility and efficiency. It has integrated robotics and a multiplate architecture that works with any conventional incubator.
In February, 2023, Discover Echo, a BICO subsidiary and a leading developer of revolutionary microscopy and imaging technologies, has introduced its newest product: the Echo Confocal microscope, a sophisticated imaging system that delivers high-resolution pictures of biological material with excellent clarity and detail
In May 2023, BD, a global medical technology company, announced the worldwide commercial launch of a new-to-the-world cell sorting instrument that incorporates two significant technologies: spectral flow cytometry and real-time imaging technology, allowing researchers to uncover previously invisible information about cells in traditional flow cytometry experiments

Acquisitions and partnerships:

In January 2023, Bruker Corporation, a producer of scientific equipment for materials and molecular research, has announced that it has acquired ACQUIFER Imaging GmbH, a company that specializes in big-data management systems for high-content microscopy and bioimaging. High-performance on-premise processing, secure storage, and networking technologies are added by this purchase to enhance Bruker\'s high-information-content advanced fluorescence microscopy imaging solutions, namely light-sheet and super-resolution microscopy products.
In August 2023, BioSkryb Genomics, a single-cell analysis company, announced a collaboration with Research Instruments Pte Ltd, a premier distributor of genomic and life science research products in Southeast Asia, to distribute BioSkryb\'s ResolveDNA and ResolveOME single cell amplification tools throughout Singapore and Southeast Asia
In February 2022, Waters Corporation, a global company focused on analytical instruments and software, announced that it has acquired the technology assets and intellectual property rights of Megadalton Solutions, Inc., an early-stage developer of Charge Detection Mass Spectrometry (CDMS) technology and services to broaden Waters Corporation\'s application in cell and gene therapy